Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,676,804
in 3 filings, $1.7M under 10b5-1 plans

Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-17 Kumar Neil CEO and President Shares withheld for taxes +16,000 $62.50 $1.0M 4,711,425
2021-02-17 Scott Randal W. Director Purchase +16,000 $62.50 $1.0M 21,000
2021-02-17 KKR Genetic Disorder L.P. 10% owner Sale −3,450,000 $60.47 $208.6M 31,060,971
2021-02-16 STEPHENSON BRIAN C See Remarks Option exercise +1,710 292,635
2021-02-16 STEPHENSON BRIAN C See Remarks Shares withheld for taxes −592 $64.98 $38K 292,043
2021-02-16 STEPHENSON BRIAN C See Remarks Option exercise · Restricted Stock Units −1,710 22,227
2021-02-16 Kumar Neil CEO and President Option exercise +5,129 4,697,564
2021-02-16 Kumar Neil CEO and President Shares withheld for taxes −2,139 $64.98 $139K 4,695,425
2021-02-16 Kumar Neil CEO and President Option exercise · Restricted Stock Units −5,129 66,682
2021-02-10 STEPHENSON BRIAN C See Remarks Grant or award · Stock Option (Right to Buy) +73,440 73,440
2021-02-10 STEPHENSON BRIAN C See Remarks Grant or award · Restricted Stock Units +12,449 12,449
2021-02-10 Kumar Neil CEO and President Grant or award · Stock Option (Right to Buy) +225,971 225,971
2021-02-10 Kumar Neil CEO and President Grant or award · Restricted Stock Units +38,306 38,306
2021-01-26 Satvat Ali J. Director Grant or award · Stock Option (Right to Buy) +39,851 39,851
2021-01-26 Satvat Ali J. Director Grant or award · Stock Option (Right to Buy) +39,851 39,851
2021-01-26 Satvat Ali J. Director Grant or award · Stock Option (Right to Buy) +79,702 79,702
2020-12-28 Turtle Cameron See Remarks Option exercise +7,500 $17.00 $128K 20,068
2020-12-28 Turtle Cameron See Remarks Option exercise +6,000 $0.34 $2K 26,068
2020-12-28 Turtle Cameron See Remarks Option exercise +6,000 $0.16 $960 32,068
2020-12-28 Turtle Cameron See Remarks Sale −10,937 $69.34 $758K 21,131

Page 40 of 44 · 868 trades